AWM
PPH icon

Apollon Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Apollon Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-32,708
Closed -$2.82M – 1262
2024
Q4 		$2.82M Buy
32,708
+4,076
+14% +$369K 0.07% 272
2024
Q3 		$2.72M Buy
28,632
+946
+3% +$89.8K 0.08% 237
2024
Q2 		$2.53M Buy
+27,686
New +$2.47M 0.08% 233

Other funds holding PPH

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Apollon Wealth Management's PPH Position: Q1 2025 in Review

Apollon Wealth Management sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2025, closing a stake of 32,708 shares — an estimated $2.82M sold.

Apollon Wealth Management first reported a position in PPH in Q2 2024 and held it in 3 quarters. The position peaked at $2.82M in Q4 2024. 136 funds tracked by Wall St. Rank hold PPH as of Q1 2025.

  • Apollon Wealth Management reported no remaining VanEck Pharmaceutical ETF position as of Q1 2025 after selling out during the quarter.
  • Apollon Wealth Management sold 32,708 VanEck Pharmaceutical ETF shares in Q1 2025, an estimated $2.82M.
  • Apollon Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and held it in 3 quarters.
  • Apollon Wealth Management's VanEck Pharmaceutical ETF position peaked at $2.82M in Q4 2024.
  • 136 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2025.

Based on Apollon Wealth Management's 13F filing for Q1 2025, filed 2 May 2025.